Through 12 months, psilocybin-assisted treatment showed to be safe and effective for major depressive disorder, researchers reported in the Journal of Psychopharmacology.
Natalie Gukasyan, MD, assistant professor of psychiatry and behavioral sciences at Johns Hopkins University in Baltimore, and colleagues conducted a randomized, waiting-list controlled study of 24 patients between the ages of 21 and 75 years, with moderate to severe unipolar depression.
Participants were randomized to either an immediate treatment, or a delayed treatment by 8 weeks, in which they received two doses of